Discover our resources, including our company information and activities
Aquilon proves the high potential of HP-Betadex in Dry Powder formulation
The BioWin-funded Aeronext research project has reached its mid-term milestone, confirming the clinical and technological potential of HP-Betadex formulations for...
Aquilon and partners cross the mid-term milestone for Aeronext
Aquilon Pharma, together with its partners, recently reached an important milestone (the “go/no go milestone” on the research part) for...
Board reshuffle at Aquilon Pharmaceuticals
Following a decision, taken during the September Board meeting, Mr Paul Maes handed over the role of Executive Chairman to...
News Release
Aquilon Pharmaceuticals has passed an important milestone in the development of its first treatment AQ001S, based on a technological complex...
Collective representative office in Texas
With the support of Awex, Revatis, Brevo Motors, Aquilon Pharma and Taipro set up a joint representative office in Texas....
New laboratories
Canal Z « Aquilon Pharma inaugure son nouveau laboratoire » The 31/01/2022 by Maxime Simon. L’Echo « Aquilon démarre une...
Aquilon Pharma launches a Phase II clinical trial for Covid19 patients in the acute respiratory phase
Aquilon Pharma is a spin-off from the University of Liège set up at the end of 2013, specializing in the...
Contact us
Do you have a question? Let's get in touch.